PreComb
2 known investors
PreComb is a Swiss biotech company developing its proprietary 3DTwin technology, which combines automated drug testing on patient-derived tumor twins with AI-guided data analysis and response prediction. The technology is designed for use in the clinic to support evidence-based, personalized treatment decisions in oncology.